Siemens Healthineers confirmed today that it has completed the acquisition of Epocal Inc. from Abbott to complete its blood gas portfolio. The closing of the deal occurred October 31, 2017. Financial details of the transaction were not disclosed.
The picture shows a blood analysis product from the epocal product line.
In integrating Epocal Inc.'s offerings into its POC Ecosystem™ solution, Siemens Healthineers enables customized testing offerings based on individual facility needs—whether that is handheld testing, benchtop solutions or central lab applications—to help improve process efficiency. The epoc® product line will integrate seamlessly into the Siemens Healthineers POC Ecosystem solution for easy connection from many manufacturers' point-of-care analyzers to hospital information systems, providing a flexible, long-term solution.
"Health networks have varying needs for blood gas testing across physicians' offices, clinics, emergency departments, laboratories and even in ambulances. Having any one solution is limiting and may not meet all patient needs, which is why customized testing solutions are so important for improving patient care," said Peter Koerte, President, Point of Care Diagnostics, Siemens Healthineers. "With a complete offering for blood gas diagnostics, we can help healthcare providers and point-of-care coordinators improve their workflows by offering the right test in the right setting at the right time."
Siemens Healthineers enables healthcare providers to achieve better outcomes at lower costs by transforming care delivery through accessible and highly efficient health care offerings.
For further information about the epoc product line, please see: www.siemens.com/epoc